Table 1.
Clinical and echocardiographic groups’ baseline characteristics
| Group 1 (n = 17) | Group 2 (n = 10) |
Group 3 (n = 17) | P value | |
|---|---|---|---|---|
| Age, y | 54.8 ± 11.9 | 59.2 ± 10.2 | 50.9 ± 12.2 | 0.14 |
| Male, n (%) | 13 (76%) | 7 (70%) | 14 (82%) | 0.18 |
| BSA (m2) | 1.9 ± 0.2 | 1.8 ± 0.2 | 1.8 ± 0.1 | 0.32 |
| EuroSCORE 2* | 0.98% | 0.96% | 0.95% | 0.45 |
| LVEF | 60.4 ± 6.4 | 58.2 ± 4.1 | 64.5 ± 4.7 | 0.32 |
| TAPSE (mm) | 24.5 ± 4.8 | 27.4 ± 5.3 | 23.5 ± 4 | 0.17 |
| SPAP (mmHg) | 33.9 ± 4.8 | 32.3 ± 5.1 | 34.9 ± 2.7 | 0.83 |
| RVEF (3D) | 62.2 ± 8.9 | 60.5 ± 8.2 | 58.5 ± 6.1 | 0.56 |
| RVSV (3D) | 68.3 ± 23.9 | 54.1 ± 18.8 | 68 ± 13.1 | 0.21 |
| RVESV (3D) | 43.4 ± 22.5 | 34.7 ± 11.7 | 48.5 ± 11.6 | 0.34Ɨ |
| RVEDV (3D) | 111.7 ± 42.8 | 88.8 ± 26.1 | 116.5 ± 19.8 | 0.18φ |
| MVP Type | ||||
| Posterior leaflet prolapse | 17 | 9 | 17 | |
| Anterior leaflet prolapse | 2 | 1 | 1 | |
*EuroSCORE 2 denotes the European System for Cardiac Operative Risk Evaluation (2nd version)
Ɨp = 0.04 Group 2 versus 3
φp = 0.03 Group 2 versus 3
BSA Indicates body surface area, LVEF Left ventricular ejection fraction, TAPSE Tricuspid annular plane systolic excursion, SPAP Systolic pulmonary arterial pressure, RVEF Right ventricular ejection fraction, RVSV Right ventricular stroke volume, RVESV Right ventricular end-systolic volume, RVEDV Right ventricular end-diastolic volume, MVP Mitral valve prolapse